The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-{2-[4-(4-Pyrrolidin-1-yl-butoxy)-phenyl]-vinyl}-benzothiazole hydrochloride hydrate ID: ALA1202629
PubChem CID: 49860315
Max Phase: Preclinical
Molecular Formula: C23H29ClN2O2S
Molecular Weight: 378.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C(=C/c1nc2ccccc2s1)\c1ccc(OCCCCN2CCCC2)cc1.Cl.O
Standard InChI: InChI=1S/C23H26N2OS.ClH.H2O/c1-2-8-22-21(7-1)24-23(27-22)14-11-19-9-12-20(13-10-19)26-18-6-5-17-25-15-3-4-16-25;;/h1-2,7-14H,3-6,15-18H2;1H;1H2/b14-11+;;
Standard InChI Key: ORFVGRWWQMDZIB-IVKCLRODSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
20.3233 1.3007 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0864 0.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8201 1.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3208 1.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0545 2.7759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5332 2.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8233 4.4074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5132 5.1381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4135 4.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5857 0.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8519 -1.1920 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3512 -1.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6160 -2.5196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1161 -2.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3513 -1.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8506 -1.2602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.0866 0.0613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5865 0.0783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8233 1.3007 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
2 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
26 18 1 0
15 27 1 0
27 28 2 0
28 12 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.54Molecular Weight (Monoisotopic): 378.1766AlogP: 5.72#Rotatable Bonds: 8Polar Surface Area: 25.36Molecular Species: BASEHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.92CX LogP: 5.52CX LogD: 3.05Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.47Np Likeness Score: -1.43
References 1. Sanfilippo PJ, Urbanski M, Press JB, Hajos ZG, Shriver DA, Scott CK.. (1988) Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity., 31 (9): [PMID:2842503 ] [10.1021/jm00117a018 ]